ArticleInternational journal of clinical oncology2014

Is intra-patient sorafenib dose re-escalation safe and tolerable in patients with advanced hepatocellular carcinoma?

Sadahisa Ogasawara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.